Search research articles
Contact Us
Filters
Showing results (51-60 of 189) with videos related to
Page
of 19
Sort By:
Oncotarget
|
May 10, 2014
A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
Alboukadel Kassambara, Claire Gourzones-Dmitriev, Surinder Sahota, et al.
International Journal of Molecular Sciences
|
April 12, 2022
Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale
Felix Jenne, Sergey Biniaminov, Nathalie Biniaminov, et al.
Haematologica
|
March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis
Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
Oncotarget
|
December 13, 2017
<i>CD24</i>, <i>CD27</i>, <i>CD36</i> and <i>CD302</i> gene expression for outcome prediction in patients with multiple myeloma
Elina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, et al.
Cytometry. Part B, Clinical Cytometry
|
November 13, 2018
BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma
Guilhem Requirand, Nicolas Robert, Stéphanie Boireau, et al.
BMC Cancer
|
May 15, 2010
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays
Karène Mahtouk, Jérôme Moreaux, Dirk Hose, et al.
Cancer
|
April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone
Ulrike Klein, Anna Jauch, Thomas Hielscher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma
Maximilian Merz, Judith Ritsch, Christina Kunz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma
Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, et al.
Hematological Oncology
|
March 16, 2013
Sorafenib in patients with refractory or recurrent multiple myeloma
Anna Yordanova, Dirk Hose, Kai Neben, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 189) with videos related to
Sort By:
Page
of 19
Oncotarget
|
May 10, 2014
A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
Alboukadel Kassambara, Claire Gourzones-Dmitriev, Surinder Sahota, et al.
International Journal of Molecular Sciences
|
April 12, 2022
Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale
Felix Jenne, Sergey Biniaminov, Nathalie Biniaminov, et al.
Haematologica
|
March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis
Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
Oncotarget
|
December 13, 2017
<i>CD24</i>, <i>CD27</i>, <i>CD36</i> and <i>CD302</i> gene expression for outcome prediction in patients with multiple myeloma
Elina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, et al.
Cytometry. Part B, Clinical Cytometry
|
November 13, 2018
BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma
Guilhem Requirand, Nicolas Robert, Stéphanie Boireau, et al.
BMC Cancer
|
May 15, 2010
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays
Karène Mahtouk, Jérôme Moreaux, Dirk Hose, et al.
Cancer
|
April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone
Ulrike Klein, Anna Jauch, Thomas Hielscher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma
Maximilian Merz, Judith Ritsch, Christina Kunz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma
Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, et al.
Hematological Oncology
|
March 16, 2013
Sorafenib in patients with refractory or recurrent multiple myeloma
Anna Yordanova, Dirk Hose, Kai Neben, et al.
Page
of 19